Artificial intelligence and personalised medicine in liver cancer
Listen to this summary
The authors explore how artificial intelligence (AI) can enhance personalized medicine in the management of liver cancer, specifically hepatocellular carcinoma and cholangiocarcinoma. They highlight the potential of AI to integrate complex multimodal data—such as clinical, imaging, and pathological information—to improve diagnosis, prognostication, and treatment selection, while also addressing the challenges of clinical translation and model interpretability. Ultimately, they suggest that successful implementation of AI-driven systems could significantly advance personalized care in this complex disease.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Journal of hepatology
View all →Sep 22, 2026 · Journal of hepatology
Restoration of aged liver regeneration by youthful systemic factors via LTβ-driven hepatocyte reprogramming
Sep 15, 2026 · Journal of hepatology
Liver transplantation for primary liver cancers in the era of transplant oncology
Sep 15, 2026 · Journal of hepatology
Advances in the imaging of liver cancer
Sep 15, 2026 · Journal of hepatology
Integrating systemic therapy in the earlier stages of liver cancer
Sep 15, 2026 · Journal of hepatology
The use of locoregional therapies in cholangiocarcinoma
Sep 15, 2026 · Journal of hepatology
Systemic therapy for HCC: Doublets, triplets and beyond
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
